01235 838 500

BOOK A TOUR
Back To News More

MitoRx Publishes Study on AP39’s Effectiveness in Reducing Obesity

October 17th 2024

MitoRx Therapeutics has published a study in Pharmacological Research demonstrating that its mitochondrial-targeted sulfide-donor compound, AP39, significantly reduces weight gain and fatty liver. This study is the first to explore the potential of mitochondrial sulfide donors in addressing obesity-related disorders.

AP39 was found to reduce weight gain by 32%, lower triglycerides, and decrease inflammatory markers, suggesting it affects lipid metabolism through the mTOR/SREBP-1/SCD1 pathway. MitoRx is developing next-generation compounds that not only combat obesity but also protect muscle, potentially addressing muscle loss associated with existing obesity treatments like GLP-1 receptor agonists.

Dr Jon Rees, CEO of MitoRx, emphasised the importance of this research in providing a new therapeutic avenue for metabolic diseases while mitigating side effects associated with current treatments. The lead author, Dr Aneta Stachowicz, highlighted the significance of this work in advancing innovative treatments for metabolic disorders through the modulation of mitochondrial signalling.

 

To read the full article or to stay up to date with further developments please follow the link – MitoRx Therapeutics Announces Publication Showing Mitochondrial Sulfide Donor AP39 Significantly Alleviates Obesity

More

April 9th 2025

Welcome to April’s Innovation Insights

Get ready for a power-packed newsletter that’s here to fuel your business growth and success! Whether you’re a start-up founder, small business owner, or seasoned entrepreneur, we’ve got something special in store just for you. Our workshops and events will cover a wide range of topics, helping you achieve your […]

Read
March 4th 2025

Quantum Data Centre Alliance Formed by Leading Tech Companies

A new Quantum Data Centre Alliance has been established, bringing together prominent technology companies including Cisco, NTT Data, OQC, QphoX, Quantinuum, QuEra, and Nu Quantum. This alliance aims to advance the development and integration of quantum technologies within data centers. By leveraging their collective expertise, the members seek to address […]

Read
February 11th 2025

Moderna’s Innovation and Technology Centre at Harwell Campus Completed

The construction of Moderna’s Innovation and Technology Centre (MITC) at Harwell Campus has been completed. This state-of-the-art facility will serve as Moderna’s base for research, development, and manufacturing. The project is part of a 10-year partnership with the UK Government, managed by the UK Health Security Agency (UKHSA). The centre […]

Read